Cancer risks for ATM variant heterozygotes.

Saved in:
Bibliographic Details
Title: Cancer risks for ATM variant heterozygotes.
Authors: Jiao Y; Inserm, U1331, Institut Curie, PSL Research University, Mines Paris, Paris, France., Goldgar DE; Inserm, U1331, Institut Curie, PSL Research University, Mines Paris, Paris, France; Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT., Le Gal D; Inserm, U1331, Institut Curie, PSL Research University, Mines Paris, Paris, France., Cavaciuti E; Inserm, U1331, Institut Curie, PSL Research University, Mines Paris, Paris, France., Beauvallet J; Inserm, U1331, Institut Curie, PSL Research University, Mines Paris, Paris, France., Dondon MG; Inserm, U1331, Institut Curie, PSL Research University, Mines Paris, Paris, France., Eon-Marchais S; Inserm, U1331, Institut Curie, PSL Research University, Mines Paris, Paris, France., Le Gall J; Department of Genetics, Institut Curie, Paris, France., Dubois d'Enghien C; Department of Genetics, Institut Curie, Paris, France., Delhomelle H; Department of Genetics, Institut Curie, Paris, France., Warcoin M; Department of Genetics, Institut Curie, Paris, France., Kluna A; Inserm, U1331, Institut Curie, PSL Research University, Mines Paris, Paris, France., Buecher B; Department of Genetics, Institut Curie, Paris, France., Castéra L; Laboratory of Cancer Biology and Genetics, Comprehensive Cancer Center François Baclesse, Caen, Inserm U1245, Rouen University, Normandy Centre for Genomic and Personalized Medicine, Rouen, France., Colas C; Department of Genetics, Institut Curie, Paris, France., Crivelli L; Centre Eugène Marquis, Rennes, France., Cusin V; Département de génétique, AP-HP, Sorbonne Université, Site Pitié-Salpêtrière, Paris, France., Garrec C; Laboratoire de Génétique Moléculaire, Service de Génétique Médicale, Centre Hospitalier Universitaire de Nantes, France., Golmard L; Department of Genetics, Institut Curie, Paris, France., Popovici C; Department of Cancer Biology, Laboratory of Molecular Oncogenetics, Institut Paoli Calmettes, Marseille, France., Sevenet N; Unité d'Oncogénétique, Institut Bergonié, Bordeaux, France., Al Saati A; Oncogenetics Laboratory, Institut Claudius Regaud, Toulouse, France., Zattara-Cannoni H; Département de génétique, CHU Timone Marseille, Marseille, France., Combes A; Genetic Oncology Department, Institut régional du Cancer de Montpellier, Arnaud de Villeneuve University Hospital, CHU Montpellier, Montpellier, France., Coupier I; Département Pathologie et Oncobiologie, CHU Montpellier, Montpellier, France., Lemonnier J; R&D UNICANCER, Fédération Nationale des Centres de Lutte Contre le Cancer, Paris, France., Caron O; Gustave Roussy, Département de médecine oncologique, Villejuif, France., Stoppa-Lyonnet D; Department of Genetics, Institut Curie, Paris, France; Université Paris-Cité, Inserm, U1339, Paris, France., Andrieu N; Inserm, U1331, Institut Curie, PSL Research University, Mines Paris, Paris, France., Lesueur F; Inserm, U1331, Institut Curie, PSL Research University, Mines Paris, Paris, France. Electronic address: fabienne.lesueur@curie.fr.
Corporate Authors: GGC investigators
Source: Genetics in medicine : official journal of the American College of Medical Genetics [Genet Med] 2026 Jul; Vol. 28 (7), pp. 102591. Date of Electronic Publication: 2026 Apr 28.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 9815831 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0366 (Electronic) Linking ISSN: 10983600 NLM ISO Abbreviation: Genet Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1530-0366
DOI:10.1016/j.gim.2026.102591